138 related articles for article (PubMed ID: 830579)
1. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
[TBL] [Abstract][Full Text] [Related]
2. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
[TBL] [Abstract][Full Text] [Related]
3. Glucose tolerance after portacaval shunt in liver cirrhosis.
Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
Holst JJ; Burcharth F; Kühl C
Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
[TBL] [Abstract][Full Text] [Related]
5. Hormonal and metabolic changes in hepatic cirrhosis.
Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H
Horm Metab Res; 1982 Jan; 14(1):34-9. PubMed ID: 7037586
[TBL] [Abstract][Full Text] [Related]
6. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
[TBL] [Abstract][Full Text] [Related]
7. Effects of portacaval shunt on the genetically obese Zucker Rat.
Pector JC; Winand J; Dehaye JP; Leclercq-Meyer V; Christophe J
Gastroenterology; 1981 Nov; 81(5):932-7. PubMed ID: 7286572
[TBL] [Abstract][Full Text] [Related]
8. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
Kabadi UM; Eisenstein AB; Tucci J; Pellicone J
Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
[TBL] [Abstract][Full Text] [Related]
9. Impact of portacaval anastomosis on plasma fatty acid profile in cirrhosis: a randomized 24-month follow-up study.
Cabré E; Navarro E; de Ramon M; Klaassen J; Planas R; Mingorance MD; Pastor MC; Lachica M; Boix J; Gassull MA
JPEN J Parenter Enteral Nutr; 1996; 20(3):198-205. PubMed ID: 8776693
[TBL] [Abstract][Full Text] [Related]
10. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
11. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
[TBL] [Abstract][Full Text] [Related]
12. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
[TBL] [Abstract][Full Text] [Related]
13. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
Dudley FJ; Alford FP; Chisholm DJ; Findlay DM
Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
15. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
16. Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial.
Aller R; de Luis DA; Izaola O; La Calle F; del Olmo L; Fernandez L; Arranz T; Hernandez JM
Diabetes Res Clin Pract; 2004 Jul; 65(1):7-11. PubMed ID: 15163472
[TBL] [Abstract][Full Text] [Related]
17. Diurnal variations in plasma insulin concentrations in normal and cirrhotic subjects: effect of dietary protein.
Fernstrom JD; Arnold MA; Wurtman RJ; Hammarstrom-Wiklund B; Munro HN; Davidson CS
J Neural Transm Suppl; 1978; (14):133-42. PubMed ID: 290734
[TBL] [Abstract][Full Text] [Related]
18. Meal frequency; does it determine postprandial lipaemia?
Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
[TBL] [Abstract][Full Text] [Related]
19. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
20. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
Kabadi UM; Kabadi MU; Premachandra BN
Am J Gastroenterol; 1991 Oct; 86(10):1504-7. PubMed ID: 1928046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
